Clinical Trials Logo

Clinical Trial Summary

The over-arching aim of this study is to evaluate the effects of two specific anti-cancer chemotherapies, vincristine and doxorubicin, on bladder function and urine composition.


Clinical Trial Description

The over-arching aim of this study is to evaluate the effects of two specific anti-cancer chemotherapies, vincristine and doxorubicin, on bladder function and urine composition. The global hypothesis is that childhood cancer survivors with prior exposure to systemic vincristine (VCR) and/or doxorubicin (DOX) report an increased incidence of bladder dysfunction (BD) symptoms on the Dysfunctional Voiding Symptom Score (DVSS) survey. We expect to observe differences in non-invasive urodynamic (niUDS) testing between childhood cancer survivors with BD symptoms on the DVSS versus those without BD symptoms on DVSS. We also expect to observe statistically significant differences in the urinary levels of known urinary biomarkers of BD (NGF, ATP and BDNF) of patients with evidence of BD compared to those without BD on the DVSS. We also expect to observe rational differences in the urinary proteome of patients between those with and without BD. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04993859
Study type Observational
Source University of Colorado, Denver
Contact Gemma Beltran
Phone (720) 777-4418
Email gemma.beltran@childrenscolorado.org
Status Recruiting
Phase
Start date June 2, 2021
Completion date July 9, 2025

See also
  Status Clinical Trial Phase
Withdrawn NCT00713921 - Neuropathic Investigation and Anticholinergic Treatment of Bladder Dysfunction in Diabetes and Stroke Patients Early Phase 1
Withdrawn NCT00472784 - Quantitative and Qualitative Changes in Neural Efferent Receptors
Completed NCT04528784 - Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis N/A
Completed NCT02910596 - Effectiveness of Bethanechol Chloride and Early Bladder Training for Prevention of Bladder Dysfunction After Radical Hysterectomy in Cervical Cancer Stage IB - IIA Phase 4
Terminated NCT00688948 - Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS) Phase 2/Phase 3
Completed NCT05858840 - Urinary Artificial Sphincter in Children
Recruiting NCT05968352 - Restoration of Bladder Function in Spinal Cord Injury
Recruiting NCT05462561 - Vascularized Composite Bladder Allograft Transplantation N/A
Completed NCT05013541 - Effect of Bladder Filling on Rectal Contractions During Cystometry
Recruiting NCT04626167 - Concomitant Renal and Urinary Bladder Allograft Transplantation Early Phase 1
Completed NCT03570593 - Removal of Urinary Catheter After Radical Surgery N/A
Active, not recruiting NCT04490642 - Linguistic Validation of the Childhood Bladder and Bowel Dysfunction Questionnaire (CBBDQ) for 5-12 Years Old in Korean
Completed NCT04057222 - Effect of Need to Void on Rectal Sensory Function in Multiple Sclerosis
Recruiting NCT04835766 - Urodynamic Changes Following Bladder Injury
Completed NCT05351138 - Comparison of Transcutaneous Electrical Nerve Stimulation and Manual Therapy in Children With Cerebral Palsy N/A
Completed NCT03987126 - Prebiotics for Spinal Cord Injury Patients With Bowel and Bladder Dysfunction Phase 3
Completed NCT01460303 - Patient-operated Valved Catheter Versus Indwelling Transurethral Catheter N/A
Completed NCT00280592 - Cranberry for Prevention of Urinary Tract Infections in Multiple Sclerosis Patients Phase 3
Completed NCT05861011 - Bladder Neck Surgery in Children With Neurogenic Bladder
Completed NCT04134104 - Incidence of The Bowel, Bladder, and Sexual Dysfunction Following Surgery for Colorectal Malignancy